1150 The Disease Burden of Chronic Hepatitis C in Turkey

Por Idilman, Ramazan
Publicado no Open Forum Infect Dis (2014)

Therapy of Delta Hepatitis

Por Yurdaydin, Cihan, Idilman, Ramazan
Publicado no Cold Spring Harb Perspect Med (2015)

A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease

Por Sayki Arslan, Muyesser, Turhan, Sibel, Dincer, Irem, Mizrak, Dilsa, Corapcioglu, Demet, Idilman, Ramazan
Publicado no Diabetol Metab Syndr (2014)

P wave dispersion is prolonged in patients with Wilson’s disease

Por Arat, Nurcan, Kacar, Sabite, Golbasi, Zehra, Akdogan, Meral, Sokmen, Yeliz, Kuran, Sedef, Idilman, Ramazan
Publicado em 2008

Evidence of oxidative injury during aging of the liver in a mouse model.

Por Colantoni, Alessandra, Idilman, Ramazan, de Maria, Nicola, Duffner, Lisa A., Van Thiel, David H., Witte, Pamela L., Kovacs, Elizabeth J.
Publicado em 2001

Impact of Periampullary Diverticula on Bile Duct Stones and Ampullary Carcinoma

Por Örmeci, Necati, Deda, Xheni, Kalkan, Çağdaş, Tüzün, Ali Emrehan, Karakaya, Fatih, Dökmeci, Abdulkadir, Bahar, D Kadir, Özkan, Hasan, İdilman, Ramazan, Çınar, Kubilay
Publicado no Euroasian J Hepatogastroenterol (2016)

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country

Por Toy, Mehlika, Onder, Fatih Oguz, Idilman, Ramazan, Kabacam, Gokhan, Richardus, Jan Hendrik, Bozdayi, Mithat, Akdogan, Meral, Kuloglu, Zarife, Kansu, Aydan, Schalm, Solko, Yurdaydin, Cihan
Publicado em 2012

Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection

Por Canini, Laetitia, Koh, Christopher, Cotler, Scott J., Uprichard, Susan L., Winters, Mark A., Han, Ma Ai Thanda, Kleiner, David E., Idilman, Ramazan, Yurdaydin, Cihan, Glenn, Jeffrey S., Heller, Theo, Dahari, Harel
Publicado no Hepatol Commun (2017)

Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction

Por Nishimura, Toshiko, Hu, Yajing, Wu, Manhong, Pham, Edward, Suemizu, Hiroshi, Elazar, Menashe, Liu, Michael, Idilman, Ramazan, Yurdaydin, Cihan, Angus, Peter, Stedman, Catherine, Murphy, Brian, Glenn, Jeffrey, Nakamura, Masato, Nomura, Tatsuji, Chen, Yuan, Zheng, Ming, Fitch, William L., Peltz, Gary
Publicado em 2013

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Por Koh, Christopher, Canini, Laetitia, Dahari, Harel, Zhao, Xiongce, Uprichard, Susan L, Haynes-Williams, Vanessa, Winters, Mark A, Subramanya, Gitanjali, Cooper, Stewart L, Pinto, Peter, Wolff, Erin F, Bishop, Rachel, Han, Ma Ai Thanda, Cotler, Scott J, Kleiner, David E, Keskin, Onur, Idilman, Ramazan, Yurdaydin, Cihan, Glenn, Jeffrey S, Heller, Theo
Publicado no Lancet Infect Dis (2015)